FDA Advisory Committee Meeting on Ampligen and Chronic Fatigue Syndrome (ME/CFS) Pt: II: the VOTE and Aftermath

Check out Part I of this series (‘FDA Advisory Committee Meeting on Ampligen Pt I: Dueling Presentation Set Stage for Critical Vote’) on the Simmaron Foundations Website hereĀ  The Vote While the FDA statistical team was highly critical of the drug, the FDA put together a Committee that gave Hemispherx … Continue reading FDA Advisory Committee Meeting on Ampligen and Chronic Fatigue Syndrome (ME/CFS) Pt: II: the VOTE and Aftermath